Human pheromones, peanut butter, and neurodegenerative disease

Peanut butter sniff test confirms Alzheimer’s University of Florida: Original Study Posted by editor@futurity.org on

Excerpt: ‘The ability to smell is associated with the first cranial nerve and is often one of the first things affected in cognitive decline. Because peanut butter is a “pure odorant,” it is only detected by the olfactory nerve and is easy to access.”

My comment: Results from the peanut butter sniff test may put my antagonist, Dr. Richard L. Doty, out of business. He markets smell tests that require too much time and extensive interpretation-based costs. Medical practitioners must refuse — based on time constraints, and costs — to use them in their practice.

Dr. Doty also has stated that mammalian pheromones do not exist. That includes human pheromones, which was the point he most wanted to make. (I know this from talking to him at the same conferences Jennifer Stamps and I attended.) More than a decade ago he was telling me and others that he was going to write a book about human pheromones.

Jennifer’s personal experience-dependent de novo creation of olfactory receptor genes, which increased her sensitivity to the chemicals in my product, exemplifies the fact that human pheromones and food odors, such as the odor of peanut butter, act via molecular mechanisms conserved in species from microbes to man. The fact that molecular mechanisms of the pathways involved are conserved refutes Doty’s academically irresponsible claim that mammalian pheromones don’t exist, which he says is because we are not like insects.

My model shows that conserved molecular mechanisms clearly link insects and microbes to a human population in what is now central China via the change in a single base pair of DNA, the smallest demonstrable change currently known. You’ll be reading more about this during the next decade, and hopefully Jennifer’s additional works will continue to link across-species examples of biologically-based cause and effect to potential treatment options that include what is known about biological facts. Those facts exclude virtually everything Doty wrote about in his book “The Great Pheromone Myth,” but include everything Bob Francoeur and I wrote about in “The Scent of Eros: Mysteries of Odor in Human Sexuality.”

The research reported by Stamps et al., in A brief olfactory test for Alzheimer’s disease, can now be linked to a patent, which suggests that human pheromones may be an effective treatment for neurodegenerative diseases: Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis. The alternative, of course, is to have someone stick a needle into your brain to inject the stem cells, which makes the work by Jennifer Stamps et al., even more important to people who have a fear of needles but do not have a fear of pheromones.

About James V. Kohl 1308 Articles
James Vaughn Kohl was the first to accurately conceptualize human pheromones, and began presenting his findings to the scientific community in 1992. He continues to present to, and publish for, diverse scientific and lay audiences, while constantly monitoring the scientific presses for new information that is relevant to the development of his initial and ongoing conceptualization of human pheromones. Recently, Kohl integrated scientific evidence that pinpoints the evolved neurophysiological mechanism that links olfactory/pheromonal input to genes in hormone-secreting cells of tissue in a specific area of the brain that is primarily involved in the sensory integration of olfactory and visual input, and in the development of human sexual preferences. His award-winning 2007 article/book chapter on multisensory integration: The Mind’s Eyes: Human pheromones, neuroscience, and male sexual preferences followed an award winning 2001 publication: Human pheromones: integrating neuroendocrinology and ethology, which was coauthored by disinguished researchers from Vienna. Rarely do researchers win awards in multiple disciplines, but Kohl’s 2001 award was for neuroscience, and his 2007 “Reiss Theory” award was for social science. Kohl has worked as a medical laboratory scientist since 1974, and he has devoted more than twenty-five years to researching the relationship between the sense of smell and the development of human sexual preferences. Unlike many researchers who work with non-human subjects, medical laboratory scientists use the latest technology from many scientific disciplines to perform a variety of specialized diagnostic medical testing on people. James V. Kohl is certified with: * American Society for Clinical Pathology * American Medical Technologists James V. Kohl is a member of: * Society for Neuroscience * Society for Behavioral Neuroendocrinology * Association for Chemoreception Sciences * Society for the Scientific Study of Sexuality * International Society for Human Ethology * American Society for Clinical Laboratory Science * Mensa, the international high IQ society